Evidence map›Paper›PMID 28370845›Full record

ArticleHuman mutation2017

Benchmarking predictions of allostery in liver pyruvate kinase in CAGI4.

Qifang Xu, Qingling Tang, Panagiotis Katsonis, Olivier Lichtarge, David Jones, Samuele Bovo, Giulia Babbi, Pier L Martelli, Rita Casadio, Gyu Rie Lee and 3 more

Abstract read
In one paragraph

Article in Human mutation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Qifang XuInstitute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Qingling TangDepartment of Biochemistry and Molecular Biology, The University of Kansas Medical Center, Kansas City, Kansas.
Panagiotis KatsonisDepartment of Human and Molecular Genetics, Baylor College of Medicine, Houston, Texas.
Olivier LichtargeDepartment of Human and Molecular Genetics, Baylor College of Medicine, Houston, Texas.
David JonesDepartment of Computer Science, University College London, London, United Kingdom.
Samuele BovoBiocomputing Group, CIG/Interdepartmental Center «Luigi Galvani» for Integrated Studies of Bioinformatics, Biophysics and Biocomplexity, University of Bologna, Bologna, Italy.
Giulia BabbiBiocomputing Group, CIG/Interdepartmental Center «Luigi Galvani» for Integrated Studies of Bioinformatics, Biophysics and Biocomplexity, University of Bologna, Bologna, Italy.
Pier L MartelliBiocomputing Group, CIG/Interdepartmental Center «Luigi Galvani» for Integrated Studies of Bioinformatics, Biophysics and Biocomplexity, University of Bologna, Bologna, Italy.
Rita CasadioBiocomputing Group, CIG/Interdepartmental Center «Luigi Galvani» for Integrated Studies of Bioinformatics, Biophysics and Biocomplexity, University of Bologna, Bologna, Italy.
Gyu Rie LeeDepartment of Chemistry, Seoul National University, Seoul, Republic of Korea.
Chaok SeokDepartment of Chemistry, Seoul National University, Seoul, Republic of Korea.
Aron W FentonDepartment of Biochemistry and Molecular Biology, The University of Kansas Medical Center, Kansas City, Kansas.
Roland L DunbrackInstitute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Funding

Functional Determinnats in G Protein-coupled ReceptorsR01GM066099 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI LICHTARGE, OLIVIER · 2003 to 2022
$7.5M
Structural Bioinformatics of Proteins and Protein Complexes and Applications to Cancer BiologyR35GM122517 · NIGMS · RESEARCH INST OF FOX CHASE CAN CTR · PI ROLAND L DUNBRACK · 2017 to 2026
$6.3M
Comparative genomics of protein structure and functionR01GM079656 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI LICHTARGE, OLIVIER · 2007 to 2019
$4.3M
Bayesian Statistics and Algorithms for Homology ModelingR01GM084453 · NIGMS · RESEARCH INST OF FOX CHASE CAN CTR · PI DUNBRACK, ROLAND L · 2008 to 2016
$2.6M
Component 2 - Resource ProjectU41HG007346 · NHGRI · UNIVERSITY OF CALIFORNIA BERKELEY · PI BRENNER, STEVEN E · 2015 to 2017
$1.7M
Dissecting Allostery in Pyruvate KinaseR01GM115340 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI FENTON, ARON W · 2016 to 2019
$1.4M
Critical Assessment of Genome Interpretation ConferenceR13HG006650 · NHGRI · UNIVERSITY OF CALIFORNIA BERKELEY · PI BRENNER, STEVEN E · 2011 to 2018
$165k
NHGRI NIH HHS R13 HG006650NHGRI NIH HHS U41 HG007346NIGMS NIH HHS R01 GM066099NIGMS NIH HHS R01 GM079656NIGMS NIH HHS R01 GM084453NIGMS NIH HHS R01 GM115340NIGMS NIH HHS R35 GM122517
6 · The paper itself

Abstract

The Critical Assessment of Genome Interpretation (CAGI) is a global community experiment to objectively assess computational methods for predicting phenotypic impacts of genomic variation. One of the 2015-2016 competitions focused on predicting the influence of mutations on the allosteric regulation of human liver pyruvate kinase. More than 30 different researchers accessed the challenge data. However, only four groups accepted the challenge. Features used for predictions ranged from evolutionary constraints, mutant site locations relative to active and effector binding sites, and computational docking outputs. Despite the range of expertise and strategies used by predictors, the best predictions were marginally greater than random for modified allostery resulting from mutations. In contrast, several groups successfully predicted which mutations severely reduced enzymatic activity. Nonetheless, poor predictions of allostery stands in stark contrast to the impression left by more than 700 PubMed entries identified using the identifiers "computational + allosteric." This contrast highlights a specialized need for new computational tools and utilization of benchmarks that focus on allosteric regulation.

Indexed as

Allosteric RegulationAllosteric SiteBenchmarkingComputational BiologyDatabases, GeneticFructosediphosphatesHumansModels, MolecularMutationPyruvate Kinasefructose-1,6-diphosphateFructosediphosphatesPyruvate Kinaseallosteric effectCAGI experimentliver pyruvate kinasemissense mutation

Identifiers

PMID28370845
PMCPMC5561472

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.